US equities
|
MU
$1,068.30
▼-1.81%
NVDA
$234.72
▼-1.16%
SNDK
$1,641.17
▼-3.03%
PLTR
$198.09
▲+2.05%
AMD
$632.07
▼-2.14%
INTC
$109.21
▼-3.46%
SPCX
$163.25
▼-2.60%
META
$719.24
▼-0.29%
MU
$1,068.30
▼-1.81%
NVDA
$234.72
▼-1.16%
SNDK
$1,641.17
▼-3.03%
PLTR
$198.09
▲+2.05%
AMD
$632.07
▼-2.14%
INTC
$109.21
▼-3.46%
SPCX
$163.25
▼-2.60%
META
$719.24
▼-0.29%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about NIDA/funded trial
Recent news which mentions NIDA/funded trial
Federal Psychedelics: $75M Grant Program, NIDA's Special Interest In State & Local Reform
June 14, 2023
Tags
Benzinga
News
Cannabis
From
Benzinga
Mydecine's Q1 2023 Reports Shows Decline In Assets And R&D, Increase In Net Loss And Accumulated Deficit
May 17, 2023
Tickers
MYCOF
Tags
Psychedelics
Earnings
Penny Stocks
From
Benzinga